End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.68 CNY | -0.72% | -1.02% | -19.13% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 11.21 for the current year.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.13% | 1.08B | - | ||
+2.15% | 3.63B | C- | ||
-22.20% | 2.16B | C+ | ||
-6.77% | 1.98B | B- | ||
+0.69% | 1.87B | - | ||
+1.86% | 1.73B | - | ||
-2.49% | 1.28B | B | ||
+4.84% | 1.18B | - | ||
-2.30% | 1.06B | - | ||
-10.19% | 858M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 002258 Stock
- Ratings Lier Chemical Co.,LTD.